Da Marvana a Sam Dunn: la cultura esoterico-occultista nel romanzo futurista di Mario Carli e Bruno Corra

Autor: Milanko, Sandra

Solo negli ultimi anni l'aspetto esoterico-occultista del secondo futurismo fiorentino, formatosi intorno alla rivista “Italia futurista”, ha destato maggior interesse tra i critici. Anche se esso rimane prevalentmente rappresentato negli articol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::19ca0e95c631ca70bbbfa050e2e3f9af
https://www.bib.irb.hr/930620

A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.

Autor: Hughes BGM; Department of Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: brett.hughes@health.qld.gov.au., Guminski A; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Bowyer S; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia., Migden MR; Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas., Schmults CD; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Khushalani NI; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, California., Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France., Lewis KD; University of Colorado Denver Cancer Center, Aurora, Colorado., Ansstas G; Department of Surgical Oncology, Washington University School of Medicine, St Louis, Missouri., Day F; Department of Medical Oncology, Calvary Mater Newcastle, Newcastle, New South Wales, Australia., Ladwa R; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Stein BN; Adelaide Cancer Centre, Adelaide, South Australia, Australia., Muñoz Couselo E; Department of Medical Oncology, Melanoma and Other Skin Tumors Unit, Vall d'Hebron University Hospital, Barcelona, Spain., Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases, Dresden, Germany., Hauschild A; Department of Dermatology, University Hospital (UKSH), Kiel, Germany., Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, NCT-West, Campus Essen and University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Basset-Seguin N; Hôpital Saint-Louis, Paris, France., Modi B; Division of Dermatology, Department of Surgery, City of Hope, Duarte, California., Dalac-Rat S; Hospital Center University Dijon Bourgogne, Dijon, France., Dunn LA; David H. Koch Center for Cancer Care, Memorial Sloan Kettering Cancer Center, New York, New York., Flatz L; University Hospital Tübingen, Tübingen, Germany., Mortier L; Centre Hospitalier Régional Universitaire de Lille (CHRU), Lille, France., Guégan S; Department of Dermatology, Hôpital Cochin, Paris, France., Heinzerling LM; Department of Dermatology, LMU University Hospital Munich, Munich, Germany; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany., Mehnert JM; Melanoma and Cutaneous Medical Oncology, Perlmutter Cancer Center, NY University, Langone Health, New York, New York., Trabelsi S; CHU de Grenoble - Hôpital A Michallon, Grenoble, France., Soria-Rivas A; Ramón y Cajal University Hospital, Spanish Society of Medical Oncology (SEOM), Madrid, Spain., Stratigos AJ; First Department of Dermatology-Venereology, Andreas Sygros Hospital, Athens, Greece; National and Kapodistrian University of Athens Medical School, Athens, Greece., Ulrich C; Charite-Universitatsmedizin Berlin, Berlin, Germany., Wong DJ; UCLA Department of Medicine, Los Angeles, California., Beylot-Barry M; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Bossi P; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy., Bugés Sánchez C; Department of Medical Oncology, Skin Tumors Unit, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital, Barcelona, Spain; Badalona-Applied Research Group in Oncology (B-ARGO), Badalona, Barcelona, Spain., Chandra S; Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Robert C; Gustave Roussy Cancer Center, Villejuif, France., Russell JS; Head and Neck/Cutaneous Medical Oncology, Huntsman Cancer Institute, Salt Lake City, Utah., Silk AW; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Booth J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Yoo SY; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Seebach F; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep 07. Date of Electronic Publication: 2024 Sep 07.

A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer.

Autor: Desilets A; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States. Electronic address: desilea@mskcc.org., Pfister DG; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Stein S; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States., Wong W; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Sherman EJ; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Fetten J; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Hung TKW; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Kriplani A; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Dunn LA; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Ho AL; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States., Michel LS; Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, United States.

Publikováno v: Oral oncology [Oral Oncol] 2024 Jul; Vol. 154, pp. 106861. Date of Electronic Publication: 2024 May 24.

Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.

Autor: Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Sherman EJ; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY., Wray R; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY., Boyle JO; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Singh B; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Grkovski M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Paudyal R; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Cunningham L; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Zhang Z; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Hatzoglou V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY., Katabi N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Diplas BH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Han J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Imber BS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Pham K; Department of Finance, Memorial Sloan Kettering Cancer Center, New York, NY., Yu Y; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Zakeri K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., McBride SM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Kang JJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Tsai CJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Chen LC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Gelblum DY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Shah JP; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Ganly I; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Cohen MA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Cracchiolo JR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Morris LGT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Dunn LA; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Michel LS; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Fetten JV; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Kripani A; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Pfister DG; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Ho AL; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Shukla-Dave A; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Humm JL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Powell SN; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Li BT; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Diaz LA; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Wong RJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 10; Vol. 42 (8), pp. 940-950. Date of Electronic Publication: 2024 Jan 19.

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.

Autor: Vos JL; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Burman B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jain S; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fitzgerald CWR; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sherman EJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dunn LA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fetten JV; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Michel LS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kriplani A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ng KK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Eng J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tchekmedyian V; Department of Medicine, Maine Medical Center-Tufts University School of Medicine, Portland, ME, USA., Haque S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Katabi N; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kuo F; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Han CY; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nadeem Z; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yang W; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Makarov V; Center for Immunotherapy and Precision Immuno-oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Srivastava RM; Center for Immunotherapy and Precision Immuno-oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Ostrovnaya I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Prasad M; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zuur CL; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Otorhinolaryngology Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands., Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pfister DG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Klebanoff CA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chan TA; Center for Immunotherapy and Precision Immuno-oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Ho AL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hoa@mskcc.org., Morris LGT; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. morrisl@mskcc.org.

Publikováno v: Nature medicine [Nat Med] 2023 Dec; Vol. 29 (12), pp. 3077-3089. Date of Electronic Publication: 2023 Aug 24.